TOKIWA-Bio
Latest round
- Series B
Last raised
- Oct 2025
Total raised
- $5.5M
Investors
- 8
About TOKIWA-Bio
Founded in 2014, based in Ibaraki, Japan. TOKIWA-Bio Inc. conducts research and develops a unique gene expression system "Stealth RNA vector (SRV)". They also develop regenerative medicine and provide support for drug discovery.
Who invested in TOKIWA-Bio
8 investors across 2 rounds
See all investors in TOKIWA-Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TOKIWA-Bio
Who invested in TOKIWA-Bio?
TOKIWA-Bio has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TOKIWA-Bio raised?
TOKIWA-Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did TOKIWA-Bio last raise money?
TOKIWA-Bio's most recent round on record is a Series B, in Oct 2025.
What does TOKIWA-Bio do?
Founded in 2014, based in Ibaraki, Japan.
Where is TOKIWA-Bio headquartered?
TOKIWA-Bio is headquartered in Tsukuba, Japan.
Which VCs invest in companies like TOKIWA-Bio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at TOKIWA-Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like TOKIWA-Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.